Ginger and perilla supplement takes on stomach troubles
NCT ID NCT07655219
First seen Jun 17, 2026 · Last updated Jun 19, 2026 · Updated 1 time
Summary
This study tests a natural supplement made from ginger and perilla (Dispepril®) to see if it can reduce stomach discomfort after eating in people with functional dyspepsia. About 400 adults will take either the supplement alone, the supplement with a half-dose of standard acid-reducing medicine, or the full-dose medicine for 14 days. The goal is to find out if the supplement works as well as standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gastroenterology Centre
Salerno, Italy
-
U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit
Montevarchi, Italy
-
University of Rome Tor Vergata
Rome, Italy
-
University of Urbino Carlo Bo
Urbino, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.